Linda Llewelyn, the Chief Individuals Officer at Well being Catalyst , Inc. (NASDAQ:HCAT), just lately offered shares of the corporate, in response to a submitting with the Securities and Change Fee. On January 15, Llewelyn offered 6,442 shares of frequent inventory at a mean worth of $5.7976 per share, totaling roughly $37,348. Following this transaction, Llewelyn retains possession of 92,260 shares within the firm. This sale was carried out beneath a pre-arranged buying and selling plan established in March 2024, in accordance with Rule 10b5-1.The sale comes as Well being Catalyst trades close to its 52-week low of $5.35, with the inventory down over 20% previously week. In keeping with InvestingPro evaluation, the inventory seems undervalued at present ranges, with analysts projecting profitability this 12 months regardless of latest market stress. InvestingPro subscribers have entry to eight further key insights about Well being Catalyst, together with detailed monetary well being scores and complete valuation metrics.
In different latest information, Well being Catalyst has been the main target of a number of vital developments. The corporate introduced a definitive settlement to accumulate Upfront Healthcare Providers (NASDAQ:HCSG), a affected person engagement platform supplier, anticipated to shut within the first quarter of 2025. This acquisition goals to boost Well being Catalyst’s current affected person engagement portfolio and streamline affected person care.
Well being Catalyst additionally disclosed its optimistic third-quarter monetary outcomes for 2024, with a income combine shifting again in direction of software program. Analyst companies akin to KeyBanc Capital Markets, Piper Sandler, and Stephens have proven optimism for the corporate’s efficiency, upgrading the inventory and elevating the value goal. KeyBanc upgraded Well being Catalyst from Sector Weight to Chubby, whereas Piper Sandler and Stephens elevated the value goal on the corporate’s inventory.
When it comes to analyst scores, RBC Capital has minimize the inventory goal for Well being Catalyst to $7, sustaining a Sector Carry out score. This choice displays the agency’s cautious stance as they monitor Well being Catalyst’s potential to transform new consumer bookings into sustained income progress. Nevertheless, the agency expressed optimism about Well being Catalyst’s bookings outlook for 2025, anticipating round 40 web new purchasers.
These are latest developments that present buyers with insights into the monetary well being and progress trajectory of Well being Catalyst. The corporate’s actions and monetary outcomes, coupled with the views of varied analyst companies, supply a snapshot of Well being Catalyst’s present enterprise panorama.
This text was generated with the help of AI and reviewed by an editor. For extra info see our T&C.
By Joey Roulette WASHINGTON (Reuters) -The U.S. Federal Aviation Administration and officers from the Turks…
TOKYO (Reuters) - Japan's core client inflation doubtless accelerated in December, boosted by increased vitality…
Eric Swayze, Govt Vice President of Analysis at Ionis Prescribed drugs Inc. (NASDAQ:IONS), a $5…
Dell's SWOT evaluation: inventory poised for AI-driven development amid market challenges
Investing.com -- World traders will lastly get to see the market impression of President-elect Donald…
By Jonathan Stempel (Reuters) - The U.S. Equal Employment Alternative (SO:FTCE11B) Fee on Friday sued…